In patients with first-episode psychosis with a full initial response
to treatment, medication continuation for at least the first 3 years
after starting treatment decreases the risk of relapse and poor
long-term clinical outcome.
http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30090-7/fulltext
Powered by LSoft's LISTSERV(R) list management software